Issue Date | Title | Author(s) |
2019-07-11 | Australia-modified Karnofsky Performance Scale and physical activity in COPD and lung cancer: an exploratory pooled data analysis. | Barbetta, C; Allgar, V; Maddocks, M; Ribeiro, C; Wilcock, A; Currow, DC; Phillips, J; Johnson, MJ |
2022-11-10 | Cyclizine pharmacovigilance in hospice/palliative care: net effects for nausea or vomiting. | McNeill, R; Prael, G; Hunt, J; Chang, S; Wilcock, A; Dunwoodie, D; Lau, C; Morgan, N; Lupati, S; Currow, DC |
2022-01-19 | Do guidelines influence breathlessness management in advanced lung diseases? A multinational survey of respiratory medicine and palliative care physicians. | Krajnik, M; Hepgul, N; Wilcock, A; Jassem, E; Bandurski, T; Tanzi, S; Simon, ST; Higginson, IJ; Jolley, CJ; BETTER-B research consortium,; Currow, D |
2020-04-08 | Managing the supportive care needs of those affected by COVID-19. | Bajwah, S; Wilcock, A; Towers, R; Costantini, M; Bausewein, C; Simon, ST; Bendstrup, E; Prentice, W; Johnson, MJ; Currow, DC; Kreuter, M; Wells, AU; Birring, SS; Edmonds, P; Higginson, IJ |
2023-01-31 | Non-steroidal anti-inflammatory drugs for pain in hospice/palliative care: an international pharmacovigilance study. | McNeill, R; Boland, JW; Wilcock, A; Sinnarajah, A; Currow, DC |
2022-10 | Paracentesis for cancer-related ascites in palliative care: An international, prospective cohort study. | Seah, DS; Wilcock, A; Chang, S; Sousa, MS; Sinnarajah, A; Teoh, CO; Allan, S; Chye, R; Doogue, M; Hunt, J; Agar, M; Currow, DC |
2018-01-01 | Pharmacovigilance in Hospice/Palliative Care: Net Effect of Haloperidol for Nausea or Vomiting | Digges, M; Hussein, A; Wilcock, A; Crawford, GB; Boland, JW; Agar, MR; Sinnarajah, A; Currow, DC; Johnson, MJ |
2015-01-01 | Practical Dyspnea Assessment: Relationship between the 0-10 Numerical Rating Scale and the Four-Level Categorical Verbal Descriptor Scale of Dyspnea Intensity | Wysham, NG; Miriovsky, BJ; Currow, DC; Herndon, JE; Samsa, GP; Wilcock, A; Abernethy, AP |
2020-02-01 | Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility) | Higginson, IJ; Wilcock, A; Johnson, MJ; Bajwah, S; Lovell, N; Yi, D; Hart, SP; Crosby, V; Poad, H; Currow, D; Best, E; Brown, S |
2015-04-01 | A systematic review of strategies used to increase recruitment of people with cancer or organ failure into clinical trials: Implications for palliative care research | Boland, J; Currow, DC; Wilcock, A; Tieman, J; Hussain, JA; Pitsillides, C; Abernethy, AP; Johnson, MJ |